Navigation Links
Regeneron Announces September 2009 Investment Conference Presentations
Date:9/10/2009

TARRYTOWN, N.Y., Sept. 10 /PRNewswire-FirstCall/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) will webcast management presentations that are scheduled for delivery later this month at the following investment conferences:

  • The Morgan Stanley Global Healthcare Unplugged Conference at 8:00 a.m. Eastern Time on Tuesday, September 15
  • The NewsMakers in the Biotech Industry Conference at 9:00 a.m. Eastern Time on Wednesday, September 16
  • The ThinkEquity Annual Growth Conference at 2:00 p.m. Eastern Time on Thursday, September 17
  • The UBS Global Life Sciences Conference at 9:00 a.m. Eastern Time on Monday, September 21

The presentation at the Morgan Stanley Global Healthcare Unplugged Conference will be a conversation with Leonard S. Schleifer, M.D., Ph.D., President and Chief Executive Officer of Regeneron, and a Morgan Stanley analyst. The presentations at the other conferences will provide an overview of the Company, including its three Phase 3 clinical programs.

The sessions may be accessed through the Company's web site, www.regeneron.com, on the Investor Relations page under the Presentations heading. Archived versions of the presentations will be available for thirty days after the live webcasts. Additional information about Regeneron and recent news releases are available on the Regeneron web site.

Regeneron is a fully integrated biopharmaceutical company that discovers, develops, and commercializes medicines for the treatment of serious medical conditions. In addition to ARCALYST(R) (rilonacept) Injection for Subcutaneous Use, its first commercialized product, Regeneron has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, inflammatory diseases, and pain, and has preclinical programs in other diseases and disorders.

    Contact Information:
    Peter Dworkin                   Laura Lindsay
    Investor Relations              Media Relations
    914.345.7640                    914.345.7800
    peter.dworkin@regeneron.com     laura.lindsay@regeneron.com


'/>"/>
SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Amedica Announces New Global Headquarters
2. Major Rollback of Pharmaceutical Bench Mark Prices Approved by Federal Court of Appeals, Hagens Berman Announces
3. TEDIndia Announces List of Inspiring Speakers from Across the Globe
4. Inverness Medical Innovations Announces September Investor Conference Schedule
5. JHD Group Announces TURNKEY EHR(TM) Service
6. SXC Health Solutions announces PBM contract renewal with Hawaii Employer-Union Health Benefits Trust Fund
7. VirtualHealth Technologies Announces Secure eHealth Agreement With DRM Security to Market Secure Document Courier and Storage Platform
8. Patriot Scientific Corporation Announces Alcon Inc.s Purchase of a Moore Microprocessor Patent(TM) Portfolio License
9. QuatRx Announces Positive Results of Second Pivotal Phase 3 Clinical Study for Ophena(TM) (Ospemifene Tablets) in Treatment of Postmenopausal Vaginal Atrophy
10. NBTY To Web Cast Presentation at CL King Best Ideas Conference; Announces Preliminary Unaudited Net Sales Results For August 2009
11. Sambazon Announces Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is helping to ... app. The fitness app plans to fix the two major problems leading the fitness industry ... fits all type program , They don’t eliminate all the reasons people quit ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Conventional wisdom ... of success. In terms of the latter, setting the bar too high can result ... more than just slow progress toward their goal. , Research from PsychTests.com ...
(Date:6/24/2016)... Dallas, Texas (PRWEB) , ... June 24, 2016 ... ... 12th International Conference and Scientific Sessions in Dallas that it will receive two ... Announcement of the grants came as PHA marked its 25th anniversary by recognizing ...
(Date:6/24/2016)... ... , ... People across the U.S. are sharpening their pencils and honing their ... in which patients and their families pay tribute to a genetic counselor by nominating ... of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: